← brief for 2026-08-21 · Slowing decline

Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach.

Article B Peer reviewed Small trial

Key takeaways

A study of 100 patients with diabetic kidney disease found that combining finerenone with an SGLT2 inhibitor reduced proteinuria (protein in urine) more than using two different types of SGLT2 inhibitors. The study was small: 100 patients, and lasted 6 months.

Who did this work

Jose A · Kamrul-Hasan ABM · Fernandez CJ · Pappachan JM

Source

Article · PubMed, the drug frontier · 2026 Sep 25
https://pubmed.ncbi.nlm.nih.gov/42626011/